| Victoria W Serralta, MD | |
|
8015 S Cooper St, Arlington, TX 76001-7018 | |
| (817) 453-4440 | |
| (817) 453-7755 |
| Full Name | Victoria W Serralta |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 23 Years |
| Location | 8015 S Cooper St, Arlington, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154366870 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | M1338 (Texas) | Primary |
| Entity Name | Dermatology & Cutaneous Surgery Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245540202 PECOS PAC ID: 2062699259 Enrollment ID: O20110616000240 |
News Archive
Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval for LATITUDE 6.0, a software upgrade to the Company's LATITUDE® Patient Management system. The LATITUDE system enables physicians to remotely monitor patients with implantable cardiac devices. The upgrade provides enhanced functionality, including the ability to view an expanded history of a patient's remote follow-up data.
Robust and widespread antibody testing has emerged as a key strategy in the fight against SARS-CoV-2, the virus responsible for the COVID-19 pandemic.
Preventable rehospitalization of the nation's older adults has proved a persistent health and financial challenge for the U.S., costing Medicare hundreds of millions of dollars each year.
Researchers at the Institute for Genomic Biology at the University of Illinois have developed a way to harness the prodigious quantities of both genomic and metabolic data being generated with high-throughput genomics and other techniques. They have developed an algorithm that automatically integrates both data sets. The model, called probabilistic regulation of metabolism (PROM), enables researchers to perturb a given regulatory gene or metabolic process and see how that affects the entire network.
Sono-Tek Corporation has announced that it is developing an entirely new generation of ultrasonic atomizing nozzles using advanced materials technology and unique new designs.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Victoria W Serralta, MD 8015 S Cooper St, Arlington, TX 76001-7018 Ph: (817) 453-4440 | Victoria W Serralta, MD 8015 S Cooper St, Arlington, TX 76001-7018 Ph: (817) 453-4440 |
News Archive
Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval for LATITUDE 6.0, a software upgrade to the Company's LATITUDE® Patient Management system. The LATITUDE system enables physicians to remotely monitor patients with implantable cardiac devices. The upgrade provides enhanced functionality, including the ability to view an expanded history of a patient's remote follow-up data.
Robust and widespread antibody testing has emerged as a key strategy in the fight against SARS-CoV-2, the virus responsible for the COVID-19 pandemic.
Preventable rehospitalization of the nation's older adults has proved a persistent health and financial challenge for the U.S., costing Medicare hundreds of millions of dollars each year.
Researchers at the Institute for Genomic Biology at the University of Illinois have developed a way to harness the prodigious quantities of both genomic and metabolic data being generated with high-throughput genomics and other techniques. They have developed an algorithm that automatically integrates both data sets. The model, called probabilistic regulation of metabolism (PROM), enables researchers to perturb a given regulatory gene or metabolic process and see how that affects the entire network.
Sono-Tek Corporation has announced that it is developing an entirely new generation of ultrasonic atomizing nozzles using advanced materials technology and unique new designs.
› Verified 4 days ago
Tri Minh Nguyen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 715 N Fielder Rd, Arlington, TX 76012 Phone: 817-261-1626 | |
Alexander L Berlin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1115 W Randol Mill Rd Ste 200, Arlington, TX 76012 Phone: 817-303-6647 Fax: 817-303-6651 | |
Dr. Todd O Moore, MD, PA Dermatology Medicare: Medicare Enrolled Practice Location: 711 E Lamar Blvd Ste 200, Arlington, TX 76011 Phone: 817-795-7546 Fax: 817-226-7546 | |
Luat Q Nguyen, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3132 Matlock Rd, 307, Arlington, TX 76015 Phone: 817-468-3131 Fax: 817-468-8936 | |
David Randal Hensley, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 300 W Arbrook Blvd, Suite D, Arlington, TX 76014 Phone: 817-701-4777 Fax: 817-701-2323 | |
Lily Y. Li, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 811 W I-20, Suite G40, Arlington, TX 76017 Phone: 817-466-8651 Fax: 817-466-2503 |